Skip to content

Osypka AG

Germany DE-MF-000005610 Last updated 22 Oct 2026

Is this your brand? Sign in to claim this brand

Devices
56
Registries
EUDAMEDGUDID
FDA recalls
0

Catalogue56

Page 1 of 2

Showing 1-50 of 56

What Osypka AG makes

Osypka AG manufactures the TME Temporary Myocardial Electrode, a device designed for temporary cardiac monitoring and stimulation during surgical procedures.

The TME Temporary Myocardial Electrode is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Osypka AG manufacture?

Osypka AG specializes in the TME Temporary Myocardial Electrode, a device used for temporary cardiac monitoring and stimulation during surgical interventions. This product is tailored for short-term clinical needs where precise heart function assessment or stimulation is required.

Where is Osypka AG based, and how does that affect its regulatory approach?

Osypka AG is based in the United States, which means its devices are subject to FDA regulations. The TME Temporary Myocardial Electrode is classified as a Class II device, indicating it poses moderate risk and requires compliance with specific FDA requirements, including the 510(k) clearance pathway for market authorization.

Which regulatory registries or databases list Osypka AG’s devices?

Osypka AG’s TME Temporary Myocardial Electrode is listed under the FDA’s 510(k) pathway, meaning it has undergone the required pre-market notification process to demonstrate substantial equivalence to a legally marketed predicate device. This classification ensures its compliance with U.S. regulatory standards.

How are Osypka AG’s devices classified under medical device regulations?

The TME Temporary Myocardial Electrode is classified as a Class II medical device by the FDA. This classification is based on its intended use—temporary cardiac monitoring and stimulation—which carries moderate risk. Class II devices require special controls beyond general controls to ensure safety and effectiveness, including performance standards and post-market surveillance.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Germany
Address
1, Earl-H.-Wood-Str., Rheinfelden, Germany
Website
www.osypka.de
Phone
+49 7623 7405 0
PRRC contact
Achim Kitschmann
EUDAMED SRN
DE-MF-000005610